Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
2013; Wiley; Volume: 28; Issue: 6 Linguagem: Inglês
10.1002/mds.25421
ISSN1531-8257
AutoresSilke Appel‐Cresswell, Carles Vilariño‐Güell, Mary Joy Encarnacion, Holly E. Sherman, Irene Yu, Brinda Shah, David Weir, Christina Thompson, Chelsea Szu‐Tu, Joanne Trinh, Jan Aasly, Alex Rajput, Ali H. Rajput, A. Jon Stoessl, Matthew J. Farrer,
Tópico(s)Neurological diseases and metabolism
ResumoABSTRACT Background Alpha‐synuclein plays a central role in the pathophysiology of Parkinson's disease. Three missense mutations in SNCA , the gene encoding alpha‐synuclein, as well as genomic multiplications have been identified as causes for autosomal‐dominantly inherited Parkinsonism. Methods Here, we describe a novel missense mutation in exon 4 of SNCA encoding a H50Q substitution in a patient with dopa‐responsive Parkinson's disease with a family history of parkinsonism and dementia. Results The variant was not observed in public databases or identified in unrelated subjects. Conclusions The substitution's evolutionary conservation and protein modeling provide additional support for pathogenicity as the amino acid perturbs the same amphipathic alpha helical structure as the previously described pathogenic mutations. © 2013 Movement Disorder Society
Referência(s)